La Dra. María Stampa defendió su tesis doctoral en IQS, en la cual ha desarrollado vectores adenoasociados híbridos para mejorar la adminsitración de material genético en el tratamiento de la Dis...
Read moreThe results, published in the journal BMC Medicine, highlight the key role of the VEGFA protein, which is linked to blood vessel formation and vascular function, in long COVID. The study shows that th...
Read moreIt has been described a new strategy based on stem cell therapy that could enhance neuronal regeneration and neuroplasticity when this vital organ is damaged. The results reveal that the use of brain-...
Read moreIt has been identified a biological target for combating spinal muscular atrophy: acid sphingomyelinase (ASM), an enzyme involved in the metabolism of lipids in the nervous system. Blocking its activi...
Read moreAn international team led by the Institut de Recerca Sant Joan de Déu (IRSJD), the Pediatric Cancer Center Barcelona of the SJD Barcelona Children’s Hospital, and the Centre for Genomic Regulation ...
Read moreThe published study now demonstrates that RAD21L also regulates the three-dimensional organisation of the genome and gene expression in sperm precursor cells. The absence of this protein causes a prof...
Read moreThe adapted vaccine, 100% produced in Spain, aligns with EMA and WHO recommendations
Read moreOn World Food Day 2025, biotechnology emerges as a driving force for building more sustainable, inclusive, and future-ready food systems.
Read moreAl principio, en cada persona infectada había muchas versiones ligeramente distintas del virus (nubes mutantes), pero en las variantes recientes esa diversidad se ha reducido
Read moreEste tipo de tumor neuroendocrino acostumbra a presentar un crecimiento lento, pese a ello, el 55% de los pacientes acaban desarrollando metástasis.
Read moreThis is a fundamental step since it opens the door to the design of new drugs, provides a new diagnostic tool and allows the development of biosensors and targeted therapies.
Read moreResults from sub-study 03A of KEYMAKER-U03, an international, open-label, rolling-arm, phase I/II umbrella trial, spotlight the promise of pembrolizumab-based regimens combined with tyrosine kinase (T...
Read more